4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... heart failure; HFpEF ... heart failure with preserved ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Heart Failure with Preserved ... Ejection Fraction: Management ... hypertension, pulmonary ... #Cardiology #HFpEF ... dCHF #Diastolic #Treatment
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
ejection fraction, treatment ... hospitalization for the management ... Spironolactone #HFpEF ... dCHF #Cardiology #EBM ... VisualAbstract #Trial